Download PDF
Thromb Haemost 1961; 6(01): 104-117
DOI: 10.1055/s-0038-1654544
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

Glas Effect and Platelet Activity in Hageman Plasma

Preben Ollendorff
1   Biological Institute of the Carlsberg Foundation, Copenhagen, Denmark
› Author Affiliations
Further Information

Publication History

Publication Date:
12 July 2018 (online)

Also available at
    Permissions and Reprints

Summary

After addition of a suspension of normal platelets the coagulation defect in Hageman plasma was corrected. The recalcification time became nearly normal and it was possible to activate the plasma by treatment with glass.

Hageman serum was unable to accelerate thromboplastin activation in normal plasma. After addition of a platelet suspension and exposure to glass the Hageman serum became as active as normal serum treated in the same way.

The results suggest that the Hageman trait might be caused by the presence of an excess of an inhibitor against glass activation and not by a deficiency in a clotting factor.

A study of previously published data on the Hageman trait shows that it is possible to explain many observations by the presence of such an inhibitor.

 

  • References

  • (1) Astrup T, Ollendorff P. Estimation of thromboplastin activation in plasma. Scand. J. clin. Lab. Invest.. 13. 1961
    PubMedSearch in Google Scholar
  • (2) Astrup T, Sjølin K.-E. Defects in Blood Coagulation. Dan. med. Bull. 4: 164-168 1957;
    PubMedSearch in Google Scholar
  • (3) Biggs R, Sharp A. A, Margolis J, Hardisty R. M, Stewart J, Davidson W. M. Defects in the Early Stages of Blood Coagulation: A Report of four Cases. Brit. J. Haem. 4: 177-191 1958;
    CrossrefPubMedSearch in Google Scholar
  • (4) Frick P. G, Hagen P. S. Severe Coagulation Defect without Haemorrhagic Symptoms Caused by a Deficiency of the Fifth Plasma Thromboplastin Precursor. J. Lab. clin. Med. 47: 592-601 1956;
    PubMedSearch in Google Scholar
  • (5) Hardisty R. M, Margolis J. The Role of Hageman Factor in the Initiation of Blood Coagulation. Brit. J. Haemat. 5: 203-211 1959;
    CrossrefPubMedSearch in Google Scholar
  • (6) Jim R. T. S, Goldfein S. Hageman Trait (Hageman Factor Deficiency). Amer. J. Med. 23: 824-831 1957;
    CrossrefPubMedSearch in Google Scholar
  • (7) Johnston Jr Ch. L, Ferguson J. H, O’Hjnlon F. A. Surface Activation of Plasma Clotting: A Function of Hageman Factor. Proc. Soc. exp. Biol. (N. Y.) 99: 197-201 1958;
    CrossrefPubMedSearch in Google Scholar
  • (8) Larrieu M. J, Soulier J.-P, Culot Y. Déficit en Facteur Hageman. Sang 28: 152-159 1957;
    PubMedSearch in Google Scholar
  • (9) Margolis J. Plasma Pain-Producing Substance and Blood Clotting. Nature 180: 1464-1465 1957;
    CrossrefPubMedSearch in Google Scholar
  • (10) Margolis J. Activation of Plasma by Contact with Glass: Evidence for a Common Reaction which releases Plasma Kinin and Initiates Coagulation. J. Physiol. 144: 1-22 1958;
    PubMedSearch in Google Scholar
  • (11) Margolis J. The Kaolin Clotting Time. J. clin. Path. 11: 406-409 1958;
    CrossrefPubMedSearch in Google Scholar
  • (12) Margolis J. Hageman Factor in Plasma Foreign Surface Reactions. Nature 182: 1102-1103 1958;
    CrossrefPubMedSearch in Google Scholar
  • (13) Margolis J. Hageman Factor and Capillary Permeability. Aust. J. exp. Biol. 37: 239-244 1959;
    PubMedSearch in Google Scholar
  • (14) Ollendorff P. Defects in and Variability of the Thromboplastic System in Horse Plasma. Thromb. Diath. haem. 4: 45-55 1959;
    PubMedSearch in Google Scholar
  • (15) Ollendorff P. Initiation of Clotting in Normal and Hageman Plasma by Glass. Nature 186: 173-174 1960;
    CrossrefPubMedSearch in Google Scholar
  • (16) Ollendorff P. Platelet Activity and Activation of Blood Clotting by Glass. Thromb. Diath. haem. 4: 410-423 1960;
    PubMedSearch in Google Scholar
  • (17) Ramot B, Singer K, Heller P, Zimmermann H. J. Hageman Factor Deficiency. Blood 11: 745-752 1956;
    PubMedSearch in Google Scholar
  • (18) Ratnoff O. D. A Familial Trait Characterized by Deficiency of a Clot-Promoting Fraction of Plasma. J. lab. Clin. Med. 44: 915-916 1954;
    PubMedSearch in Google Scholar
  • (19) Ratnoff O. D. Mechanism of Blood Coagulation. Connective Tissue, Thrombosis, and Arteriosclerosis. 213-222 Academic Press; New York, London: 1959
    Search in Google Scholar
  • (20) Ratnoff O. D, Colopy J. E. A Familial Hemorrhagic Trait associated with a Deficiency of a Clot-promoting Fraction of Plasma. J. clin. Invest. 34: 602-613 1955;
    CrossrefPubMedSearch in Google Scholar
  • (21) Ratnoff O. D, Margolius Jr A. Hageman Trait: An Asymptomatic Disorder of Blood Coagulation. Transaction of the Association of American Physicians LXVIII: 149 1955;
    PubMedSearch in Google Scholar
  • (22) Ratnoff O. D, Rosenblum J. M. The Role of Hageman Factor in the Initiation of Clotting by Glass. J. Lab. clin. Med. 50: 941-942 1957;
    PubMedSearch in Google Scholar
  • (23) Ratnoff O. D, Rosenblum J. M. Role of Hageman Factor in the Initiation of Clotting by Glass. Evidence that Glass Frees Hageman Factor from Inhibition. Amer. J. Med. 25: 160-168 1958;
    CrossrefPubMedSearch in Google Scholar
  • (24) Sjølin K.-E. Deficiency of the Hageman Factor Demonstrated by the Thrombin Generation Test. Thromb. Diath. haem. 1: 153-157 1957;
    PubMedSearch in Google Scholar
  • (25) Sjølin K.-E. The Hageman Trait in a Family with Haemorrhagic Diathesis. Acta genet. (Basel) 7: 541-548 1957;
    PubMedSearch in Google Scholar
  • (26) Sjølin K.-E. Coagulation Defect in Horse Plasma. Proc. Soc. exp. Biol (N Y) 94: 818-820 1957;
    CrossrefPubMedSearch in Google Scholar
  • (27) Soulier J.-P, Larrieu M. J. Deficit en 3’eme facteur prothromboplastiaue plasmatique. Rapport entre le PTA et le facteur Hageman. Thromb. Diath. haem. 2: 1-23 1958;
    PubMedSearch in Google Scholar
  • (28) Soulier J.-P, Prou-Wartelle O. New Data on Hageman Factor and Plasma Thromboplastin Antecedent: The Role of “Contact” in the Initial Phase of Blood Coagulation. Brit. J. Haemat. 6: 88-101 1960;
    CrossrefPubMedSearch in Google Scholar
  • (29) Soulier J.-P, Prou-Wartelle O. Nouvelles Données sur les Facteur Hageman et PTA et sur le “Contact”. Rev. franç. Ét. clin. biol. 4: 932-938 1960;
    PubMedSearch in Google Scholar
  • (30) Soulier J.-P, Wartelle O, Ménaché D. Hageman Trait and PTA Deficiency; the Role of Contact of Blood with Glass. Brit. J. Haemat. 5: 121-138 1959;
    CrossrefPubMedSearch in Google Scholar
  • (31) Vroman L. Surface Contact on Thromboplastin Formation. Thesis Utrecht: 1958
    Search in Google Scholar
  • (32) Wartelle O. Mechanisme de la coagulation chez la poule. I. Etudes des éléments du “complexe prothrombique” et de la thromboplastinoformation. Rev. Hémat. 12: 351-387 1957;
    PubMedSearch in Google Scholar